Optimization of X-linked chronic granulomatous disease modelization by using patient-specific induced pluripotent stem cells - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Experimental Hematology Année : 2013

Optimization of X-linked chronic granulomatous disease modelization by using patient-specific induced pluripotent stem cells

Résumé

Induced pluripotent stem cells (iPSCs) are reprogrammed somatic cells with embryonic stem cell (ESC)-like characteristics generated by the introduction of combinations of specific transcription factors. Patient-specific iPSCs can be used to recapitulate disease-specific phenotypes for the screening of new therapies. Chronic granulomatous disease (CGD), a rare inherited immunodeficiency, is characterized by recurrent and severe infections in childhood. The most frequent form is the X-linked CGD (X-CGD) due to mutations in CYBB leading to the absence of Nox2 of the phagocytic NADPH oxidase complex, responsible for the production of microbicidal reactive oxygen species.

Dates et versions

hal-02294296 , version 1 (23-09-2019)

Identifiants

Citer

Julie Brault, Erwan Goutagny, Tomo Saric, Karl-Heinz Krause, Marie-José Stasia, et al.. Optimization of X-linked chronic granulomatous disease modelization by using patient-specific induced pluripotent stem cells. Experimental Hematology, 2013, 41 (8), pp.S28. ⟨10.1016/j.exphem.2013.05.112⟩. ⟨hal-02294296⟩
1017 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More